TP53 and carcinoma: Consequently, deletion of p53, when evident in prostatic adenocarcinoma, cannot be considered specific of or relevant for the genesis of this tumor, but although the patients studied had no evidence of carcinoma, they may still develop prostate cancer or may have a latent disease that was not detected.